Literature DB >> 18249246

Mitochondrial pathophysiology, reactive oxygen species, and cardiovascular diseases.

Ling Gao1, Karine Laude, Hua Cai.   

Abstract

This article discusses mitochondrial pathophysiology, reactive oxygen species, and cardiovascular diseases. Mitochondrial respiratory chains are responsible for energy metabolism/ATP production through the tricyclic antidepressant cycle, coupling of oxidative phosphorylation, and electron transfer. The mitochondrion produces reactive oxygen species as "side products" of respiration. The mitochondrial derived reactive oxygen species is involved in the pathogenesis of various clinical disorders including heart failure, hypoxia, ischemia/reperfusion injury, diabetes, neurodegenerative diseases, and the physiologic process of aging. Observational and mechanistical studies of these pathologic roles of mitochondria are discussed in depth in this article.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18249246      PMCID: PMC2700041          DOI: 10.1016/j.cvsm.2007.10.004

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  95 in total

Review 1.  The contribution of mitochondria to common disorders.

Authors:  Gregory M Enns
Journal:  Mol Genet Metab       Date:  2003 Sep-Oct       Impact factor: 4.797

2.  Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide.

Authors:  Enzo Nisoli; Emilio Clementi; Clara Paolucci; Valeria Cozzi; Cristina Tonello; Clara Sciorati; Renata Bracale; Alessandra Valerio; Maura Francolini; Salvador Moncada; Michele O Carruba
Journal:  Science       Date:  2003-02-07       Impact factor: 47.728

Review 3.  Mitochondrial formation of reactive oxygen species.

Authors:  Julio F Turrens
Journal:  J Physiol       Date:  2003-10-15       Impact factor: 5.182

4.  Mitochondrial dysfunction leads to telomere attrition and genomic instability.

Authors:  Lin Liu; James R Trimarchi; Peter J S Smith; David L Keefe
Journal:  Aging Cell       Date:  2002-10       Impact factor: 9.304

5.  Embryonic fibroblasts from Gpx4+/- mice: a novel model for studying the role of membrane peroxidation in biological processes.

Authors:  Qitao Ran; Holly Van Remmen; Mingjun Gu; Wenbo Qi; L Jackson Roberts; Tomas Prolla; Arlan Richardson
Journal:  Free Radic Biol Med       Date:  2003-11-01       Impact factor: 7.376

Review 6.  The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases.

Authors:  Hua Cai; Kathy K Griendling; David G Harrison
Journal:  Trends Pharmacol Sci       Date:  2003-09       Impact factor: 14.819

7.  Diabetes-induced mitochondrial dysfunction in the retina.

Authors:  Renu A Kowluru; Saiyeda Noor Abbas
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-12       Impact factor: 4.799

Review 8.  Structure, mechanism and regulation of peroxiredoxins.

Authors:  Zachary A Wood; Ewald Schröder; J Robin Harris; Leslie B Poole
Journal:  Trends Biochem Sci       Date:  2003-01       Impact factor: 13.807

9.  The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults.

Authors:  Levi J Yant; Qitao Ran; Lin Rao; Holly Van Remmen; Toru Shibatani; Jason G Belter; Lucia Motta; Arlan Richardson; Tomas A Prolla
Journal:  Free Radic Biol Med       Date:  2003-02-15       Impact factor: 7.376

Review 10.  Analysis of glutathione: implication in redox and detoxification.

Authors:  Anna Pastore; Giorgio Federici; Enrico Bertini; Fiorella Piemonte
Journal:  Clin Chim Acta       Date:  2003-07-01       Impact factor: 3.786

View more
  38 in total

1.  Acute oxidative stress can reverse insulin resistance by inactivation of cytoplasmic JNK.

Authors:  Alina Berdichevsky; Leonard Guarente; Avirup Bose
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

2.  Vascular endothelial mitochondrial oxidative stress in response to preeclampsia: a role for angiotension II type 1 autoantibodies.

Authors:  Evangeline Deer; V Ramana Vaka; Kristen M McMaster; Kedra Wallace; Denise C Cornelius; Lorena M Amaral; Mark W Cunningham; Babbette LaMarca
Journal:  Am J Obstet Gynecol MFM       Date:  2020-10-27

Review 3.  Regulation of mitophagy by the ubiquitin pathway in neurodegenerative diseases.

Authors:  Shyamal Desai; Meredith Juncker; Catherine Kim
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-09

Review 4.  Estrogen and mitochondria function in cardiorenal metabolic syndrome.

Authors:  Guanghong Jia; Annayya R Aroor; James R Sowers
Journal:  Prog Mol Biol Transl Sci       Date:  2014       Impact factor: 3.622

Review 5.  Mitochondrial function in hypoxic ischemic injury and influence of aging.

Authors:  P Benson Ham; Raghavan Raju
Journal:  Prog Neurobiol       Date:  2016-06-16       Impact factor: 11.685

6.  Regulatory role of mitochondria in oxidative stress and atherosclerosis.

Authors:  Jui-Chih Chang; Shou-Jen Kou; Wei-Ting Lin; Chin-San Liu
Journal:  World J Cardiol       Date:  2010-06-26

7.  Redox-Dependent Calpain Signaling in Airway and Pulmonary Vascular Remodeling in COPD.

Authors:  Laszlo Kovacs; Yunchao Su
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

Review 8.  Mitochondrial functional impairment in response to environmental toxins in the cardiorenal metabolic syndrome.

Authors:  Guanghong Jia; Annayya R Aroor; Luis A Martinez-Lemus; James R Sowers
Journal:  Arch Toxicol       Date:  2015-01-06       Impact factor: 5.153

Review 9.  NADPH oxidases as a source of oxidative stress and molecular target in ischemia/reperfusion injury.

Authors:  Pamela W M Kleikers; K Wingler; J J R Hermans; I Diebold; S Altenhöfer; K A Radermacher; B Janssen; A Görlach; H H H W Schmidt
Journal:  J Mol Med (Berl)       Date:  2012-10-23       Impact factor: 4.599

10.  Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of Thioredoxin 2.

Authors:  Julian D Widder; Daniela Fraccarollo; Paolo Galuppo; Jason M Hansen; Dean P Jones; Georg Ertl; Johann Bauersachs
Journal:  Hypertension       Date:  2009-06-08       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.